Literature DB >> 8878613

Effects of cyclophosphamide and ceftriaxone on gastrointestinal colonization of mice by Candida albicans.

G Samonis1, N C Karyotakis, E J Anaissie, E Barbounakis, S Maraki, Y Tselentis, G P Bodey.   

Abstract

Adult male Crl:CD1 (ICR) mice were fed chow containing Candida albicans to induce sustained gastrointestinal colonization by the yeast. Groups of mice were rendered neutropenic with cyclophosphamide and subsequently received ceftriaxone, while other groups received normal saline and served as controls. Stool cultures were obtained immediately before and at the end of treatment. The administration of cyclophosphamide substantially increased the C. albicans counts in the stools of mice. The addition of ceftriaxone to the cyclophosphamide regimen did not significantly increase the level of gastrointestinal colonization by C. albicans. There was no evidence of Candida dissemination to internal organs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8878613      PMCID: PMC163505     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man.

Authors:  E J Freireich; E A Gehan; D P Rall; L H Schmidt; H E Skipper
Journal:  Cancer Chemother Rep       Date:  1966-05

2.  Candidiasis in cancer patients.

Authors:  G P Bodey
Journal:  Am J Med       Date:  1984-10-30       Impact factor: 4.965

3.  Candida albicans translocation across the gut mucosa following burn injury.

Authors:  S Inoue; J A Wirman; J W Alexander; O Trocki; R R Cardell
Journal:  J Surg Res       Date:  1988-05       Impact factor: 2.192

4.  Systemic and gastrointestinal candidiasis of infant mice after intragastric challenge.

Authors:  L M Pope; G T Cole; M N Guentzel; L J Berry
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

5.  Systemic candidiasis from Candida albicans colonizing the gastrointestinal tract of mice.

Authors:  T Umenai; S Konno; N Ishida
Journal:  Experientia       Date:  1979-10-15

6.  Prospective study of the impact of broad-spectrum antibiotics on the yeast flora of the human gut.

Authors:  G Samonis; A Gikas; P Toloudis; S Maraki; G Vrentzos; Y Tselentis; N Tsaparas; G Bodey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-08       Impact factor: 3.267

7.  Correlation between in vivo and in vitro studies of modulation of resistance to experimental Candida albicans infection by cyclophosphamide in mice.

Authors:  F Bistoni; M Baccarini; E Blasi; P Marconi; P Puccetti; E Garaci
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

8.  Pathogenicity of Candida tropicalis and Candida albicans after gastrointestinal inoculation in mice.

Authors:  J R Wingard; J D Dick; W G Merz; G R Sandford; R Saral; W H Burns
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

9.  Persistence and spread of Candida albicans after intragastric inoculation of infant mice.

Authors:  L H Field; L M Pope; G T Cole; M N Guentzel; L J Berry
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

10.  Effects of cyclophosphamide on murine candidiasis.

Authors:  S A Moser; J E Domer
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

View more
  3 in total

1.  Development of an orogastrointestinal mucosal model of candidiasis with dissemination to visceral organs.

Authors:  Karl V Clemons; Gloria M Gonzalez; Gaurav Singh; Jackie Imai; Marife Espiritu; Rachana Parmar; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

2.  Enterogenous infection of Candida albicans in immunocompromised rats under severe acute pancreatitis.

Authors:  Xiang-Wang Zhao; Lei Yan; Dan Xu; Yu-Hui Cui; Chun-Hui Yang; Yan-Jun Zhou; Jian-Guo Tang
Journal:  World J Emerg Med       Date:  2016

Review 3.  Animal models: an important tool in mycology.

Authors:  Javier Capilla; Karl V Clemons; David A Stevens
Journal:  Med Mycol       Date:  2007-12       Impact factor: 4.076

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.